Turnstone Biologics Overview

  • Founded
  • 2015
Founded
  • Status
  • Private
  • Employees
  • 91
Employees
  • Latest Deal Type
  • Corporate
  • Latest Deal Amount
  • $120M
Latest Deal Amount
  • Investors
  • 10

Turnstone Biologics General Information

Description

Developer of viral immunotherapies designed to deliver breakthrough cancer immunotherapies to improve survival for people with cancer. The company's immunotherapies combine a bio-selected and engineered oncologic virus to directly lyse tumors with a potent vaccine technology to drive tumor-antigen specific T-cell responses, enabling bio-medical professionals to generate immune responses, treat cancer and modulate tumor environment.

Contact Information

Website
www.turnstonebio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Drug Delivery
Biotechnology
Primary Office
  • 12 York Street
  • 3rd Floor
  • Ottawa, Ontario K1N 5S6
  • Canada
+1 (613) 000-0000

Turnstone Biologics Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Turnstone Biologics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Corporate 19-Dec-2019 $120M 00000 Completed Generating Revenue
4. Later Stage VC (Series C) 04-Jan-2019 0000 000.00 Completed Startup
3. Early Stage VC (Series B) 02-Nov-2016 000.00 000.00 Completed Startup
2. Early Stage VC (Series A) 28-Oct-2015 $11.3M $11.3M Completed Startup
1. Early Stage VC 04-May-2015 Completed Startup
To view Turnstone Biologics’s complete valuation and funding history, request access »

Turnstone Biologics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of viral immunotherapies designed to deliver breakthrough cancer immunotherapies to improve survival for peopl
Drug Discovery
Ottawa, Canada
91 As of 2021
00000
000000000000 00000

0000000

xercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in repreh
0000 000000000
Houston, TX
00 As of 0000
000.00
000000000 - 000.00

00000000

commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu
0000000000000
Seal Beach, CA
000 As of 0000
00.00
000000000 - 00.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Turnstone Biologics Competitors (26)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
DNAtrix Venture Capital-Backed Houston, TX 00 000.00 000000000 - 000.00
00000000 Venture Capital-Backed Seal Beach, CA 000 00.00 000000000 - 00.00
000000 Venture Capital-Backed Seattle, WA 00 000.00 0000000000 0 000.00
000000000000 00000 Venture Capital-Backed Tokyo, Japan 0 000.00 0000000000 0 000.00
000 0000000000000 Formerly VC-backed Princeton, NJ 00 00.000 000000 - 000 00.000
You’re viewing 5 of 26 competitors. Get the full list »

Turnstone Biologics Executive Team (13)

Name Title Board Seat Contact Info
Sammy Farah Ph.D Chief Executive Officer, President & Board Member
José Otero Ph.D Chief Technical Officer
Saryah Azmat Chief Business Officer
David Stojdl Ph.D Scientific Co-Founder & Senior Vice President, Discovery Research
Steve Bernstein MD Senior Vice President, Clinical Research & Development
You’re viewing 5 of 13 executive team members. Get the full list »

Turnstone Biologics Board Members (9)

Name Representing Role Since
Ben Auspitz F-Prime Capital Board Member 000 0000
Bradley Bolzon Ph.D Versant Ventures Board Member 000 0000
Jerel Davis Ph.D Versant Ventures Board Member 000 0000
Patrick Machado JD Self Board Member 000 0000
Rishi Gupta JD OrbiMed Board Member 000 0000
You’re viewing 5 of 9 board members. Get the full list »

Turnstone Biologics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Turnstone Biologics Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Takeda Pharmaceutical Company Corporation Minority 000 0000 000000 0
Brace Pharma Capital Corporate Venture Capital Minority 000 0000 000000 0
Eight Roads Venture Capital Minority 000 0000 000000 0
Sectoral Asset Management Asset Manager Minority 000 0000 000000 0
Teralys Capital Fund of Funds Minority 000 0000 000000 0
You’re viewing 5 of 10 investors. Get the full list »

Turnstone Biologics Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000 000000000000 20-Jan-2021 000000000000000000 Biotechnology 00000 00000 00.0
To view Turnstone Biologics’s complete acquisitions history, request access »

Ready to get started?

Request a free trial